Marketing-authorisation holder
STALLERGENES Sas
4 medicines in 2 countries, as authorisation holder.
Loading your pageโฆ
Marketing-authorisation holder
4 medicines in 2 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ORALAIRCompressa sublinguale | Estratto allergeni polline graminaceee- dactylis glomerata l., Estratto allergeni polline graminaceee-lolium perenne l., Estratto allergeni polline graminaceee-phleum pratense l., Estratto allergeni polline graminaceee-anthoxanthum odoratum l., Estratto allergeni polline graminaceee-poa pratensis l. | Italy | Authorised | |
| Oralair300 ir tabs/ct ยท Tablet | Sweet vernal, orchard, perennial rye, timothy,, Kentucky blue grass mixed pollens allergen extract | United States | Marketed | 2014 |
| ORYLMYTECompressa sublinguale | Estratto allergeni acari della polvere domestica-dermatophagoides pteronyssinus, Estratto allergeni acari della polvere domestica-dermatophagoides farinae | Italy | Authorised | |
| PALFORZIAPolvere orale in capsule da aprire | Food | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 3 | 3 | 0 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.